Literature DB >> 10950839

Effect of CCK pretreatment on the CCK sensitivity of rat polymodal gastric vagal afferent in vitro.

J Y Wei1, Y H Wang.   

Abstract

To prevent the blood-borne interference and reflex actions via neighboring organs and the central nervous system, the study was conducted in an in vitro isolated stomach-gastric vagus nerve preparation obtained from overnight-fasted, urethan-anesthetized rats. Afferent unit action potentials were recorded from the gastric branch of the vagus nerve. The left gastric artery was catheterized for intra-arterial injection. In vitro we found that 1) 55/70 gastric vagal afferents (GVAs) were polymodal, responding to CCK-8 and mechanical stimuli, 13 were mechanoreceptive, and 2 were CCK-responsive; 2) sequential or randomized intra-arterial injections of CCK-8 (0.1-200 pmol) dose-dependently increased firing rate and reached the peak rate at 100 pmol; 3) the action was suppressed by CCK-A (Devazepide) but not by CCK-B (L-365,260) receptor antagonist; 4) neither antagonist blocked the mechanosensitivity of GVA fibers. These results are consistent with corresponding in vivo well-documented findings. Histological data indicate that the layered structure of the stomach wall was preserved in vitro for 6-8 h. Based on these results, it seems reasonable to use the in vitro preparation for conducting a study that is usually difficult to be performed in vivo. For instance, because there was no blood supply in vitro, the composition of the interstitial fluid, i.e., the ambient nerve terminals, can be better controlled and influenced by intra-arterial injection of a defined solution. Here we report that acutely changing the ambient CCK level by a conditioning stimulus (a preceding intra-arterial injection of increasing doses of CCK-8) reduced the CCK sensitivity of GVA terminals to a subsequent test stimulus (a constant dose of CCK-8 intra-arterial injection).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950839     DOI: 10.1152/ajpendo.2000.279.3.E695

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  4 in total

1.  Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.

Authors:  J Kong; J Chuddy; I A Stock; P M Loria; S V Straub; C Vage; K O Cameron; S K Bhattacharya; K Lapham; K F McClure; Y Zhang; V M Jackson
Journal:  Br J Pharmacol       Date:  2016-03-17       Impact factor: 8.739

2.  Mechanosensitive duodenal afferents contribute to vagal modulation of inflammation in the rat.

Authors:  Frederick Jia-Pei Miao; Paul G Green; Jon D Levine
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

3.  Essential elements for glucosensing by gastric vagal afferents: immunocytochemistry and electrophysiology studies in the rat.

Authors:  Gintautas Grabauskas; Shi-Yi Zhou; Yuanxu Lu; Il Song; Chung Owyang
Journal:  Endocrinology       Date:  2012-12-04       Impact factor: 4.736

4.  Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor-mediated pathway to inhibit gastric motor function in the rat.

Authors:  Jörg Glatzle; Yuhua Wang; David W Adelson; Theodore J Kalogeris; Tilman T Zittel; Patrick Tso; Jen-Yu Wei; Helen E Raybould
Journal:  J Physiol       Date:  2003-05-23       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.